Parapneumonic Effusion: Clinical Trials

4 trials for Parapneumonic Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2
Not applicable1Completed 1

Follow Parapneumonic Effusion: new trials by email Literature Review of Parapneumonic Effusion trials Research Report on Parapneumonic Effusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metagenomic Study in Parapneumonic Effusion
16S rRNA gene amplicon sequencing - Parapneumonic Effusion
RecruitingChinese University of Hong Kong1152023-06-012023-06-29
Management of Pleural Space Infections
Intrapleural Medications, Surgery, Pleural Sampling - Empyema, Pleural, Parapneumonic Effusion
Phase 4CompletedSwedish Medical Center262019-04-012022-11-22
Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
VATS Decortication, Fibrinolytic Therapy - Parapneumonic Effusion, Empyema, Pleural
Not applicableCompletedDenver Health and Hospital Authority102018-07-262022-01-27
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase), Medical Thoracoscopy - Pleural Infection, Empyema
Phase 4CompletedTulane University322017-11-012021-02-04

Narrower conditions

Empyema, Pleural (2)  ·  Empyema (1)  ·  Hemostatic Disorders (1)  ·  Pleural Diseases (1)  ·  Pneumonia (1)

Broader conditions

Infections (3)  ·  Inflammation (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiratory Tract Diseases (3)  ·  Suppuration (3)  ·  Empyema (2)  ·  Pleural Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Lung Diseases (1)  ·  Vascular Diseases (1)

Interventions

Deoxyribonucleases (1)  ·  Quality of Life (1)  ·  Surgical Procedures, Operative (1)  ·  Thoracoscopy (1)  ·  Thrombolytic Therapy (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Denver Health and Hospital Authority (1)  ·  Swedish Medical Center (1)  ·  Tulane University (1)

Countries

United States (3)  ·  Hong Kong (1)

Top investigators

Fayez Kheir, MD, MSc (1)  ·  Fredric Pieracci, MD, MPH (1)  ·  Jed Gorden, MD (1)

Results publications

PMID 37043201, PMID 38710463